Evolutionary Genomics

Evolutionary Genomics FCF Yield

The Free Cash Flow Yield of Evolutionary Genomics (FNAM) as of Nov 21, 2026 is -48,153.86 %. In the previous year, Free Cash Flow Yield was -118,939.39 % — a change of -59.51% (higher).

FCF Yield

-48,153.86 %

YoY

-59.51%

Last updated:

Free Cash Flow Yield of Evolutionary Genomics is 2022 -48,153.86 % . Free Cash Flow Yield of Evolutionary Genomics was 2021 -118,939.39 % . It decreases by -59.51% higher compared to the previous year.

The Evolutionary Genomics FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2015
-52,082.27 USD
Jan 1, 2016
-90,878.75 USD
Jan 1, 2017
-88,449.61 USD
Jan 1, 2018
-56,259.29 USD
Jan 1, 2019
-47,029.18 USD
Jan 1, 2020
-172,595.09 USD
Jan 1, 2021
-118,939.39 USD
Jan 1, 2022
-48,153.86 USD
The Evolutionary Genomics FCF Yield history
YEARFCF YieldYoY
-48,153.86 %-59.51%
-118,939.39 %-31.09%
-172,595.09 %+267.00%
-47,029.18 %-16.41%
-56,259.29 %-36.39%
-88,449.61 %-2.67%
-90,878.75 %+74.49%
-52,082.27 %+2,569.73%
-1,950.84 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Evolutionary Genomics Stock analysis

What does Evolutionary Genomics do? Evolutionary Genomics, Inc. generates revenue through the identification and validation of genes impacting commercially valuable traits in crops for the agriculture industry. The company utilizes its Adapted Traits Platform (ATP) to identify genes that control important traits in plants and animals, focusing on yield increases in corn and rice, drought tolerance, sugar content in tomatoes, and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The firm applies ATP in research projects for agricultural clients seeking improved crop performance. The company targets agricultural industry clients who require gene-based solutions for enhancing crop traits such as yield, drought tolerance, and pest resistance. The Adapted Traits Platform (ATP) is central to the company's product offering, enabling throughput molecular evolution analysis through non-synonymous site (Ka) and synonymous site (Ks) analysis to identify positively selected genes. This platform identifies genes that have successfully adapted to impart new or improved traits in agricultural crops. The firm's research projects include specific applications like yield increases in corn and rice, drought tolerance in crops, and pest resistance in soybeans, cassava, beans, tomatoes, and cotton. Agricultural companies and research institutions are the primary buyers of these gene identification services. Evolutionary Genomics, Inc. focuses on the agriculture industry, specifically targeting clients who need gene validation for crop improvement. The company's services are used to identify genes responsible for commercially valuable traits such as yield, drought tolerance, and pest resistance. The firm's ATP platform is applied in research projects for crops including corn, rice, soybeans, cassava, beans, tomatoes, and cotton. Agricultural clients seeking to enhance their crop traits through gene-based solutions are the key market segment for the company's offerings. Evolutionary Genomics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolutionary Genomics stock

Free Cash Flow Yield of Evolutionary Genomics is -48,153.86 % in 2022.

Free Cash Flow Yield of Evolutionary Genomics changed from -118,939.39 % to -48,153.86 %, representing a -59.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Evolutionary Genomics since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Evolutionary Genomics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Evolutionary Genomics

All Key Metrics — Evolutionary Genomics